Abivax SA

ABVX

$91.44

Name : Abivax SA

Sector : Healthcare

Industry: Biotechnology

Mark. Cap: $8,004,793,856.00

EPSttm : -6.08

Abivax SA

$91.44

1.60%

$1.44

ABVX — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

9.15

Margin Of Safety %

Put/Call OI Ratio

0.36

EPS Next Q Diff

0.82

EPS Last/This Y

1.22

EPS This/Next Y

0.34

Price

91.29

Target Price

157.26

Analyst Recom

1.28

Performance Q

-28.3

Upside

-188.1%

Beta

1.52

Ticker: ABVX

22 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-10-12	ABVX	86.94	0.43	0.17	220526
2026-10-13	ABVX	86.18	0.43	0.17	225814
2026-10-14	ABVX	87.92	0.41	0.57	232608
2026-10-15	ABVX	92.51	0.41	1.16	236622
2026-10-16	ABVX	88.2	0.40	2.60	241357
2026-10-19	ABVX	87.52	0.40	0.22	201489
2026-10-20	ABVX	92.56	0.40	0.18	205145
2026-10-21	ABVX	93.49	0.39	0.33	209304
2026-10-22	ABVX	90.31	0.39	0.39	211225
2026-10-23	ABVX	88.07	0.39	1.12	212491
2026-10-26	ABVX	86.5	0.36	0.24	201375
2026-10-27	ABVX	87.06	0.35	0.19	203269
2026-10-28	ABVX	89.84	0.35	0.19	204720
2026-10-29	ABVX	89.14	0.35	0.48	206501
2026-10-30	ABVX	86.68	0.35	0.64	208103
2026-11-02	ABVX	84.82	0.35	0.20	202745
2026-11-03	ABVX	88.7	0.35	0.32	203902
2026-11-04	ABVX	89.41	0.35	1.48	205828
2026-11-05	ABVX	84.11	0.36	0.16	209328
2026-11-06	ABVX	85.71	0.36	0.34	211511
2026-11-09	ABVX	87.09	0.36	0.15	206532
2026-11-10	ABVX	89.94	0.36	0.17	207255
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

22 items 1 of 1

23 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-10-12	ABVX	86.93	63.5	-	-4.24
2026-10-13	ABVX	86.23	63.5	-	-4.24
2026-10-14	ABVX	88.01	63.5	-	-4.24
2026-10-15	ABVX	92.36	65.2	-	-4.19
2026-10-16	ABVX	88.10	65.2	-	-4.19
2026-10-19	ABVX	87.50	65.2	-	-4.19
2026-10-20	ABVX	87.50	65.2	-	-4.19
2026-10-21	ABVX	92.44	65.2	-	-4.19
2026-10-22	ABVX	90.30	65.2	-	-4.18
2026-10-23	ABVX	88.00	65.2	-	-4.18
2026-10-26	ABVX	86.49	65.3	-	-4.17
2026-10-27	ABVX	87.03	65.3	-	-4.17
2026-10-28	ABVX	89.82	65.3	-	-4.17
2026-10-29	ABVX	89.08	65.3	-	-4.17
2026-10-30	ABVX	86.68	65.3	-	-4.17
2026-11-02	ABVX	84.85	65.3	-	-4.17
2026-11-03	ABVX	88.66	65.3	-	-4.17
2026-11-04	ABVX	89.51	65.3	-	-4.17
2026-11-05	ABVX	84.18	65.3	-	-4.17
2026-11-06	ABVX	85.68	65.3	-	-4.17
2026-11-09	ABVX	87.01	65.3	-	-4.17
2026-11-10	ABVX	90.05	65.3	-	-4.17
2026-11-11	ABVX	91.29	65.3	-	-4.17
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

23 items 1 of 1

21 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-10-12	ABVX	0.00	13.76	9.81
2026-10-13	ABVX	0.00	13.76	9.81
2026-10-14	ABVX	0.00	13.76	9.81
2026-10-15	ABVX	0.00	13.76	9.81
2026-10-16	ABVX	0.00	13.76	9.81
2026-10-19	ABVX	0.00	10.89	9.81
2026-10-20	ABVX	0.00	10.89	9.81
2026-10-21	ABVX	0.00	10.89	9.81
2026-10-22	ABVX	0.00	10.89	9.81
2026-10-23	ABVX	0.00	10.89	9.81
2026-10-26	ABVX	0.00	10.62	9.81
2026-10-27	ABVX	0.00	10.62	9.15
2026-10-28	ABVX	0.00	10.62	9.15
2026-10-29	ABVX	0.00	10.62	9.15
2026-10-30	ABVX	0.00	10.62	9.15
2026-11-02	ABVX	0.00	10.62	9.15
2026-11-03	ABVX	0.00	10.62	9.15
2026-11-05	ABVX	0.00	10.62	9.15
2026-11-06	ABVX	0.00	10.62	9.15
2026-11-09	ABVX	0.00	10.49	9.15
2026-11-10	ABVX	0.00	10.49	9.15
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

21 items 1 of 1

Last Quarter Act. EPS

-1.71

Avg. EPS Est. Current Quarter

-0.86

Avg. EPS Est. Next Quarter

-0.89

Insider Transactions

Institutional Transactions

10.49

Beta

1.52

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

38.7

Max Drawdown 5-Year %

Target Price

157.26

P/E

Forward P/E

PEG

P/S

P/B

17.15

P/Free Cash Flow

EPS

-6.1

Average EPS Est. Cur. Y

-4.17

EPS Next Y. (Est.)

-3.84

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

-100

Return on Equity vs Industry %

-100

EPS 1 7Days Diff

EPS 1 30Days Diff

-0.59

EBIT Estimation

◆ ABVX Healthcare

$90.00

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

2/20

Pullback

17/25

Volume

4/15

Valuation

12/20

TP/AR

2/10

Options

8/10

RSI

49.4

Range 1M

48.5%

Sup Dist

4.5%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

1/25

Growth

9/30

Estimates

0/20

Inst/Vol

6/15

Options

8/10

EPS Yr

24.8%

EPS NY

5.3%

52W%

25.3%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟢 BUY +74.7% upside

Quality

2/30

Valuation

12/30

Growth

7/25

Stability

7/10

LT Trend

1/5

Upside

+74.7%

Quality

ABVX — P/E HistoricalBiotechnology

Abivax SA

Sector: Healthcare

Industry: Biotechnology

Employees: 98

ABIVAX Société Anonyme, a clinical-stage biotechnology company, develops therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. Its lead drug candidate includes obefazimod, which is in Phase 3 clinical development for the treatment of moderately to severely active UC, as well as Phase 2b clinical trials for Crohn's disease. The company was incorporated in 2013 and is headquartered in Paris, France.

ABVX

Latest News

—

Caricamento notizie per ABVX…

stock quote shares ABVX – Abivax ADR Stock Price stock today

news today ABVX – Abivax ADR stock forecast ,stock prediction 2023 2024 2025

marketwatch ABVX – Abivax ADR yahoo finance google finance

stock history ABVX – Abivax ADR invest stock market

stock prices ABVX premarket after hours

ticker ABVX fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: ABVX

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

Last Quarter Act. EPS

Average EPS Est. Cur. Y